• Mitochondrial Calcium Suppresses Ferroptosis via GPX4 Acetyl

  2026-04-15

  The referenced study uncovers a direct mechanistic link between mitochondrial calcium signaling and ferroptosis suppression in cancer cells. By elucidating how the mitochondrial calcium uniporter (MCU) maintains GPX4 activity through acetylation, the research provides new insight into metabolic and epigenetic regulation of cancer cell survival.

• Cisplatin and the Modulation of DNA Damage Response: New Ins

  2026-04-14

  Explore how Cisplatin (CDDP) not only drives apoptosis but also intersects with Wnt and EGFR pathways, reshaping the DNA damage response in cancer research. This article uncovers advanced mechanistic insights and protocol recommendations, offering a unique perspective beyond traditional cisplatin applications.

• Optimized hiPSC Differentiation Yields Functional Platelets

  2026-04-13

  This study presents a systematically optimized protocol for differentiating human induced pluripotent stem cells (hiPSCs) into functional platelets, addressing cost, yield, and efficiency limitations of previous methods. The findings offer a practical, scalable approach for ex vivo platelet production, with implications for cell therapy and regenerative medicine.

• PPP1R3G/PP1γ Regulation of RIPK1: Implications for Cell Deat

  2026-04-13

  This study uncovers the critical role of PPP1R3G in recruiting PP1γ to dephosphorylate RIPK1, thereby promoting RIPK1-dependent apoptosis and necroptosis. These findings illuminate a previously uncharacterized regulatory mechanism in cell death and inflammation, with significant implications for inflammation research and cancer biology.

• Vardenafil HCl Trihydrate: Advancing Proteoform-Specific PDE

  2026-04-12

  Explore how Vardenafil HCl Trihydrate empowers next-generation, proteoform-resolved PDE5 inhibition assays. This article reveals new insights into selectivity, cGMP pathway modulation, and the practical impact of native membrane proteomics.

• Patient-Derived Gastric Cancer Assembloids Enhance Drug Resp

  2026-04-12

  This study presents a novel gastric cancer assembloid model that integrates matched tumor organoids and autologous stromal cell subpopulations, more closely capturing the cellular heterogeneity and microenvironmental influences of primary tumors. The model provides deeper insight into gene expression, drug response variability, and resistance mechanisms, establishing a robust platform for personalized cancer research.

• Cisplatin (CDDP) in Cancer Research: Protocols & Innovations

  2026-04-11

  Cisplatin (CDDP) remains the gold-standard agent for dissecting apoptosis and chemoresistance in cancer models. This article delivers actionable protocols, troubleshooting strategies, and highlights the synergy of Cisplatin in targeting cancer stemness, as demonstrated in the latest oral cancer research.

• Applied Workflows for Mifepristone (RU486) in Cancer & Repro

  2026-04-11

  Mifepristone (RU486) offers precise, reproducible control over progesterone receptor signaling in both oncology and reproductive biology models. This article details optimized protocols, troubleshooting strategies, and advanced use-cases to help researchers harness APExBIO’s high-purity Mifepristone for robust, publication-ready results.

• ECL Chemiluminescent Substrate Detection Kit: Precision for

  2026-04-10

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) from APExBIO empowers researchers to detect low-abundance proteins with exquisite sensitivity and stability. Its extended signal duration and low background noise redefine immunoblotting, especially for challenging biomarker discovery workflows.

• Mifepristone (RU486): Unveiling Advanced Mechanisms and N...

  2026-04-10

  Explore the multifaceted role of Mifepristone as a progesterone receptor antagonist in cancer and reproductive biology research. This article dives deeper into molecular mechanisms, cell signaling, and translational models, setting a new benchmark for scientific rigor and application insights.

• Mifepristone (RU486): Pioneering Tumor Suppression and Pr...

  2026-04-09

  Explore how Mifepristone (RU486), a potent progesterone receptor antagonist, enables advanced research into tumor suppression, cell signaling, and therapy resistance in heterogeneous cancer models. This article uncovers novel mechanistic insights and experimental strategies, providing a distinct perspective for scientists seeking translational impact.

• Optimizing Endothelial and pH Assays with 5-(N,N-dimethyl...

  2026-04-08

  This scenario-driven guide demonstrates how 5-(N,N-dimethyl)-Amiloride (hydrochloride) (SKU C3505) addresses key challenges in cell viability, ion transport, and endothelial injury assays. Drawing on quantitative data and validated best practices, we show how researchers can achieve robust, reproducible results in intracellular pH and Na+/H+ exchanger studies using this trusted APExBIO reagent.

• Scenario-Driven Solutions with Ciprofloxacin (hydrochlori...

  2026-04-08

  This article presents scenario-based guidance for biomedical researchers and laboratory professionals seeking robust, reproducible outcomes in cell viability and cytotoxicity assays. By addressing real-world challenges, we demonstrate how Ciprofloxacin (hydrochloride) (SKU C5539) from APExBIO enables quantitative reliability and experimental agility, supported by peer-reviewed evidence.

• Fluorescein TSA Fluorescence System Kit: Signal Amplifica...

  2026-04-07

  The Fluorescein TSA Fluorescence System Kit enables ultrasensitive, specific detection of low-abundance biomolecules in fixed cells and tissues using tyramide signal amplification. This tyramide signal amplification fluorescence kit provides high spatial resolution and robust signal enhancement for immunohistochemistry, immunocytochemistry, and in situ hybridization applications.

• Recombinant Human EGF: Mechanistic Insights and Next-Gen ...

  2026-04-07

  Explore the unique biological activities and advanced applications of recombinant human EGF, including its role in cell migration, mucosal protection, and cancer research. This in-depth article reveals new perspectives on EGF signaling, referencing the latest mechanistic studies and highlighting APExBIO's high-quality EGF for innovative research.

11263 records 1/751 page Next 12345 下5页 Last page